Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 221

1.

[Efficacy and safety of Entecavir monotherapy switched from Lamivudine combined Adefovir Dipivoxil for chronic hepatitis B virus-related compensated liver cirrhosis].

Lai XJ, Lian JS, Chen JY, Zhang YM, Jia HY, Zheng L, Yang YD.

Zhonghua Gan Zang Bing Za Zhi. 2018 Feb 20;26(2):113-118. doi: 10.3760/cma.j.issn.1007-3418.2018.02.008. Chinese.

PMID:
29804377
2.

Switching Lamivudine with Adefovir Dipivoxil Combination Therapy to Entecavir Monotherapy Provides Better Viral Suppression and Kidney Safety.

Lian JS, Zhang XL, Lu YF, Chen JY, Zhang YM, Jia HY, Zhang Z, Yang YD.

Int J Med Sci. 2019 Jan 1;16(1):17-22. doi: 10.7150/ijms.28700. eCollection 2019.

3.

De novo combined lamivudine and adefovir dipivoxil therapy vs entecavir monotherapy for hepatitis B virus-related decompensated cirrhosis.

Lian JS, Zeng LY, Chen JY, Jia HY, Zhang YM, Xiang DR, Yu L, Hu JH, Lu YF, Zheng L, Li LJ, Yang YD.

World J Gastroenterol. 2013 Oct 7;19(37):6278-83. doi: 10.3748/wjg.v19.i37.6278.

4.

[Entecavir 1.0mg monotherapy or entecavir plus adefovir dipivoxil for patients with lamivudine-resistant chronic hepatitis B had suboptimal response to lamivudine plus adefovir dipivoxil].

Xing J, Han T, Liu L, Li Y, Li J, Li Y, Xiao SX.

Zhonghua Gan Zang Bing Za Zhi. 2011 Nov;19(11):828-32. doi: 10.3760/cma.j.issn.1007-3418.2011.11.009. Chinese.

PMID:
22433304
5.

Virologic responses to add-on adefovir dipivoxil treatment versus entecavir monotherapy in children with lamivudine-resistant chronic hepatitis B.

Chu M, Cho SM, Choe BH, Cho MH, Kwon S, Lee WK.

J Pediatr Gastroenterol Nutr. 2012 Dec;55(6):648-52. doi: 10.1097/MPG.0b013e318262a737.

PMID:
22688509
6.

Rescue therapy for lamivudine-resistant chronic hepatitis B: comparison between entecavir 1.0 mg monotherapy, adefovir monotherapy and adefovir add-on lamivudine combination therapy.

Kim HJ, Park JH, Park DI, Cho YK, Sohn CI, Jeon WK, Kim BI.

J Gastroenterol Hepatol. 2010 Aug;25(8):1374-80. doi: 10.1111/j.1440-1746.2010.06381.x.

PMID:
20659226
7.

[Compare the effect of combined therapy between telbivudine plus adefovir dipivoxil and lamivudine plus adefovir dipivoxil corresponding to renal function in patients with hepatitis B virus infection].

Xu J, Bao L, Wang Y, Yang L, Li WT, Zhao ZH, Li Y.

Zhonghua Gan Zang Bing Za Zhi. 2018 Apr 20;26(4):288-293. doi: 10.3760/cma.j.issn.1007-3418.2018.04.011. Chinese.

PMID:
29996341
8.

Long-term outcomes of two rescue therapies in lamivudine-refractory patients with chronic hepatitis B: combined lamivudine and adefovir, and 1-mg entecavir.

Ze E, Baek EK, Lee JJ, Chung HW, Ahn DG, Cho HJ, Kwon JC, Kim HJ, Lee H.

Clin Mol Hepatol. 2014 Sep;20(3):267-73. doi: 10.3350/cmh.2014.20.3.267. Epub 2014 Sep 25.

9.

Efficacy of lamivudine combined with adefovir dipivoxil versus entecavir monotherapy in patients with hepatitis B-associated decompensated cirrhosis: A meta-analysis.

Peng H, Liu J, Yang M, Tong S, Yin W, Tang H, Hu P, Hu H, Ren H.

J Clin Pharmacol. 2014 Feb;54(2):189-200. doi: 10.1002/jcph.181. Epub 2013 Oct 4.

PMID:
24105676
10.
11.

Antiviral efficacies of currently available rescue therapies for multidrug-resistant chronic hepatitis B.

Park MS, Kim BK, Kim KS, Kim JK, Kim SU, Park JY, Kim DY, Baartarkhuu O, Han KH, Chon CY, Ahn SH.

Clin Mol Hepatol. 2013 Mar;19(1):29-35. doi: 10.3350/cmh.2013.19.1.29. Epub 2013 Mar 25.

12.

Treatment response and evolution of HBV resistance during lamivudine plus adefovir or entecavir therapy in patients with adefovir-resistant mutants.

Chen CH, Wang JH, Lu SN, Hu TH, Hung CH, Chang MH, Changchien CS, Lee CM.

Antivir Ther. 2012;17(4):701-9. doi: 10.3851/IMP2074. Epub 2012 Feb 23.

PMID:
22358132
13.

Efficacy of entecavir in patients with chronic hepatitis B resistant to both lamivudine and adefovir or to lamivudine alone.

Shim JH, Suh DJ, Kim KM, Lim YS, Lee HC, Chung YH, Lee YS.

Hepatology. 2009 Oct;50(4):1064-71. doi: 10.1002/hep.23145.

PMID:
19637288
14.
15.

Comparison of lamivudine plus adefovir therapy versus entecavir with or without adefovir therapy for adefovir-resistant chronic hepatitis B.

Kang SH, Yim HJ, Kim HR, Kang K, Suh SJ, Lee HJ, Yoon EL, Kim JH, Seo YS, Yeon JE, Byun KS.

J Clin Gastroenterol. 2014 Nov-Dec;48(10):889-95. doi: 10.1097/MCG.0000000000000066.

PMID:
24440937
17.
18.
20.

Efficacy of combined therapy in patients with hepatitis B virus-related decompensated cirrhosis.

Lv GC, Yao JM, Yang YD, Zheng L, Sheng JF, Chen Y, Li LJ.

World J Gastroenterol. 2013 Jun 14;19(22):3481-6. doi: 10.3748/wjg.v19.i22.3481.

Supplemental Content

Support Center